Corporate Investor

Updated:

Jeekai & Partners

Robin R. Zhao's Jeekai & Partners deploys capital into intellectual property assets from Beijing, a pure-play IP investor operating since 1998.

Jeekai & Partners

Jeekai & Partners was established in Beijing in 1998 by Robin R. Zhao. The firm functions as a corporate investor with a mandate centered entirely on intellectual property — a configuration that separates it from peers pursuing equity, credit, or real assets. Zhao operates as Senior Partner, with Mo Guo managing patent administration and Xiaoman Gu having previously held a partner role after beginning her IP career at the firm. Investment activity is concentrated in Chinese intellectual property markets. Rather than taking equity stakes in operating companies, the firm acquires, develops, and monetizes patent portfolios and trademark assets directly. This IP-centric deployment model means the portfolio consists of legal rights rather than conventional securities. The firm maintains memberships in four IP industry associations — the International Trademark Association, the International Association for the Protection of Intellectual Property, the China Trademark Association, and the All-China Patent Agents Association — reinforcing its position within China's IP ecosystem. Scale metrics remain opaque. The firm does not publicly disclose assets under management or deployment totals. Its operational footprint appears limited to a single office in Beijing. A dedicated philanthropic vehicle, the Beijing Jiekai Cardiovascular Health Foundation, operates alongside the investment entity. No fund structures, co-investment vehicles, or external LP relationships have been made public. Jeekai's structural distinction lies in being a pure-play IP investment firm within a market where intellectual property monetization remains less institutionalized than in the United States or Europe. The combination of a corporate investor structure with an industry-association network and a separate health foundation creates an architecture that does not map cleanly to Western family office or asset manager categories.

General information

Firm type

Corporate Investor

Year founded

1998

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Principals

Robin R. Zhao

Founder, Senior Partner

Mo Guo

Manager, Patent Administration Department

Xiaoman Gu

Former Partner

Sector focus

Intellectual Property

Frequently asked questions

How does Jeekai & Partners generate returns from intellectual property?

The firm acquires, develops, and monetizes patent portfolios and trademarks — generating returns through licensing agreements, IP sales, and enforcement of rights rather than through equity appreciation or interest income. This model requires deep expertise in Chinese patent law and administrative processes, which the firm's leadership has cultivated since 1998.

Who leads investment strategy at Jeekai & Partners?

Founder Robin R. Zhao sets strategic direction as Senior Partner. Day-to-day patent portfolio management is handled by Mo Guo, who leads the patent administration department. Former partner Xiaoman Gu began her career at the firm, building expertise in Chinese IP practice.

Does Jeekai & Partners accept outside capital or operate as a family office?

The firm is structured as a corporate investor rather than a family office and does not publicly disclose external LP relationships. No fund vehicles or co-investment structures have been made public, suggesting the firm deploys proprietary capital.

What is the Beijing Jiekai Cardiovascular Health Foundation?

It is a philanthropic entity operating alongside the investment firm, focused on cardiovascular health. The foundation represents the Zhao family's charitable activity separate from the IP investment operations, though governance overlap between the two entities has not been publicly detailed.

How is Jeekai & Partners connected to China's IP regulatory ecosystem?

The firm holds memberships in China's primary IP trade bodies — the China Trademark Association and the All-China Patent Agents Association — plus two international associations, INTA and AIPPI. These connections provide both policy insight and professional standing within China's evolving intellectual property framework.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo